Analysis of cranio-facial deformities caused by abnormal endochondral ossification

软骨内骨化异常所致颅面部畸形分析

基本信息

  • 批准号:
    13671896
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Achondroplasia and chondrodysplaisa, both of which are congenital deformities, are caused by constitutively-active forms of FGFR3 and PTH/PTHrP receptor, respectively. We have attempted to clarify which of FGFR3 and PTHrP show predominant function on chondrocyte differentiation. Furthermore, PTHrP has a nucleolar targeting signal in the internal region., without mediating the common receptor with PTH. Thus, we examined the biological action of PTHrPand FGFR3 in cartilage development.(1)The 18-day-old fetus with null mutation of FGFR3/PTHrP genes revealed shorted limbs, consistent with the abnormalities of the PTHrP^<-/-> fetuses. The FGFR3^<-/->/PTHrP^<-/-> compound mutant fetuses showed reduced numbers of epiphyseal chondrocytes and a form of chondrodysplasia, which are characteristic features of the PTHrP^<-/-> fetus. Therefore, PTHrP appeared to function predominantly to FGFR3, or to lie down-stream of PTHrP on chondrocyte proliferation. However, the numbers of apoptotic chondrocytes were significantly reduced in FGFR3^<-/->/PTHrP^<-/-> fetuses, compared with that of PTHrP^<-/-> fetus. In addition, the FGFR3^<-/-> and the compound fetuses revealed the markedly reduced expression of VEGF in the hypertrophic zone, whereas the PTHrP deficient fetus displayed the abundant mRNA of VEGF in the matched region. Thus, FGFR3 appears to act functionally in the upstream to PTHrP signaling on proliferating chondrocytes, as well as to act independently on hypertrophic chondrocytes.(2)The majority of the biological activity of PTHrP is mediated through the binding to the common receptor with PTH. However, PTHrP shows a nucleolar targeting signal in the internal region. Chondrocytic cell line transfected with truncated forms of PTHrP cDNA showed this peptide in the nucleoli mediated by translation initiating from AUG-codon and alternatively initiating from CUG codons.
软骨发育不全和软骨发育不良都是先天性畸形,分别由 FGFR3 和 PTH/PTHrP 受体的组成型活性形式引起。我们试图阐明 FGFR3 和 PTHrP 中哪一个在软骨细胞分化中显示出主要功能。此外,PTHrP在内部区域具有核仁靶向信号,而不介导与PTH的共同受体。因此,我们检测了PTHrP和FGFR3在软骨发育中的生物学作用。(1)FGFR3/PTHrP基因无效突变的18天胎儿显示出四肢短小,与PTHrP^</-/->胎儿的异常一致。 FGFR3^</->/PTHrP^</-/->复合突变胎儿表现出骨骺软骨细胞数量减少和某种形式的软骨发育不良,这是PTHrP^</-/->胎儿的特征。因此,PTHrP 似乎主要对 FGFR3 起作用,或者在软骨细胞增殖方面位于 PTHrP 的下游。然而,与PTHrP^-/-胎儿相比,FGFR3^-/->/PTHrP^-/-胎儿中凋亡软骨细胞的数量显着减少。此外,FGFR3^-/-和复合胎儿显示肥厚区VEGF表达显着降低,而PTHrP缺陷胎儿在匹配区域显示丰富的VEGF mRNA。因此,FGFR3 似乎在增殖软骨细胞上的 PTHrP 信号传导上游发挥功能,并且独立地作用于肥大软骨细胞。(2)PTHrP 的大部分生物活性是通过与 PTH 共同受体结合介导的。然而,PTHrP 在内部区域显示核仁靶向信号。用截短形式的PTHrP cDNA转染的软骨细胞系显示,该肽在核仁中由从AUG密码子起始或从CUG密码子起始的翻译介导。

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Arai S, Amizuka N, et al.: "Osteoclastogenesis-related antigen, a novel molecule on mouse stromal cells, regulates osteoclastogenesis"J Bone Miner.Res.. 18. 686-695 (2003)
Arai S、Amizuka N 等人:“破骨细胞生成相关抗原,小鼠基质细胞上的一种新型分子,调节破骨细胞生成”J Bone Miner.Res.. 18. 686-695 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Amizuka N, Henderson JE, et al.: "Morphological approach to biological action of PTHrP and vitamin D3 on endochondral ossification"J Oral Biosciences. (in press).
Amizuka N、Henderson JE 等人:“PTHrP 和维生素 D3 对软骨内骨化的生物作用的形态学方法”J Oral Biosciences。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ito M, Amizuka N, et al.: "Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells"J Bone Miner Metab.. 21. 353-362 (2003)
Ito M、Amizuka N 等人:“关于 PTHrP 分泌肿瘤细胞、基质细胞和骨细胞之间可能相互作用的超微结构和细胞生物学研究”J Bone Miner Metab.. 21. 353-362 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Amizuka N, Henderson JE, et al.: "Signalling by fibroblast growth factor receptor 3(FGFR3) and Parathyroid Hormone Related Peptide(PTHrP) coordinate Cartilage and Bone development."Bone. 34-1. 13-25 (2003)
Amizuka N、Henderson JE 等人:“成纤维细胞生长因子受体 3 (FGFR3) 和甲状旁腺激素相关肽 (PTHrP) 发出的信号协调软骨和骨骼发育。”骨骼。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Amizuka, N., Oda, K.et al.: "The biological action of parathyroid hormone(PTH)-related peptide(PTHrP) mediated either by the PTH/PTHrP receptor or he nucleolar translocation in diondrocytes."Anat Sci.Int.. 77. 225-236 (2002)
Amizuka, N., Oda, K.等:“甲状旁腺激素 (PTH) 相关肽 (PTHrP) 的生物学作用由 PTH/PTHrP 受体或软骨细胞中的核仁易位介导。”Anat Sci.Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMIZUKA Norio其他文献

AMIZUKA Norio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMIZUKA Norio', 18)}}的其他基金

Minimodeling - a novel manner of bone formation: Investigation of "minimodeling factors" from osteocytes
微型模型——一种新的骨形成方式:骨细胞“微型模型因子”的研究
  • 批准号:
    21K19585
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis on ON-OFF switiching for osteocytic differentitation
骨细胞分化的ON-OFF转换分析
  • 批准号:
    18K19628
  • 财政年份:
    2018
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Bone-specific action of parathyroid hormone on membrane transporters and enzymes involved in phosphate ion supplement
甲状旁腺激素对参与磷酸盐离子补充的膜转运蛋白和酶的骨特异性作用
  • 批准号:
    18H02964
  • 财政年份:
    2018
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Sorting of secretory proteins trafficking and mini-modeling induction by osteocyte network
骨细胞网络对分泌蛋白运输的分类和微型建模诱导
  • 批准号:
    16K15771
  • 财政年份:
    2016
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Biological synthesis of phosphate ions and its feedback mechanism of osteocyte
磷酸根离子的生物合成及其骨细胞的反馈机制
  • 批准号:
    15H05010
  • 财政年份:
    2015
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel biological actions of PTH mediated by osteocyte network - mini-modeling and osteocytic osteolysis
骨细胞网络介导的 PTH 的新生物学作用 - 微型模型和骨细胞骨质溶解
  • 批准号:
    26670797
  • 财政年份:
    2014
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Regulation of bone minerals by FGF23/klotho axis related to osteocytic function
FGF23/klotho 轴对骨矿物质的调节与骨细胞功能相关
  • 批准号:
    24390406
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A new approach to the different biological function of PTH and PTHrP on osteoblastic cells
探讨 PTH 和 PTHrP 对成骨细胞不同生物学功能的新方法
  • 批准号:
    24659808
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanism of osteocyte lacunar canalicular system on PTH and bone quality
骨细胞腔隙微管系统对PTH和骨质量影响的分子机制
  • 批准号:
    18390487
  • 财政年份:
    2006
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The analyses on bone and cartilage diseases caused by mutations of FGFR3/PTHrP genes
FGFR3/PTHrP基因突变引起的骨与软骨疾病分析
  • 批准号:
    16390524
  • 财政年份:
    2004
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了